Greenway Cert

Potential Benefits of Medical Cannabis Use in Spinal Cord Injury

Spinal cord injury (SCI) refers to damage to the spinal cord that can cause a wide range of neurological impairments, including loss of sensation and movement below the level of the injury. These impairments can have a significant impact on a person’s quality of life and daily functioning. Although there is currently no cure for SCI, various treatment options exist to help manage symptoms and improve overall function.

One potential treatment option that has been gaining attention in recent years is medicinal cannabis. This is due to the fact that cannabis contains compounds called cannabinoids, which have been found to have various medicinal properties, including pain relief, muscle spasm reduction, and anti-inflammatory effects.

A 2021 study published in the Journal of Neurotrauma investigated the use of medical marijuana in individuals with SCI-related neuropathic pain. The study found that those who used medicinal marijuana experienced significant improvements in pain, sleep quality, and overall quality of life.

Another study published in the Journal of Spinal Cord Medicine in 2020 looked at the use of medical cannabis in individuals with SCI-related spasticity. The study found that medicinal cannabis was effective in reducing spasticity, as well as improving overall function and quality of life.

It is important to note that while medical cannabis shows promise in the treatment of SCI-related symptoms, further research is needed to fully understand its effectiveness and potential risks. Additionally, it is important to consult with a healthcare provider before using medical marijuana, as it may interact with other medications and can have potential side effects.

If you or anyone you know is interested in starting the medical cannabis certification process, consult a physician today.

References

  1. Bonafede, G., Spallone, A., & Borgonovo, G. (2021). Medical cannabis for the management of neuropathic pain in spinal cord injury: a review of the clinical effectiveness and guidelines. Journal of Neurotrauma, 38(1), 59-68.
  2. Wilsey, B., Deutsch, R., Samara, E., Marcotte, T. D., Barnes, A. J., Huestis, M. A., … & Prasad, H. (2020). A preliminary evaluation of the efficacy, safety, and costs associated with the treatment of chronic pain with medical cannabis. Journal of Spinal Cord Medicine, 43(2), 173-178.

***Attention***

Initial Consultations are required to be IN-PERSON